1. Targeting Sphingolipids for Cancer Therapy
   Osmel Companioni et al, 2021, Frontiers in Oncology CrossRef
2. Combined effect of midostaurin and sphingosine kinase-1 inhibitor on FMS-like tyrosine kinase 3 (FLT3) wild type acute myeloid leukemia cells
   Hande Nur Şahin et al, 2022, Turkish Journal of Biochemistry CrossRef
3. Advancements on the Multifaceted Roles of Sphingolipids in Hematological Malignancies
   Yasharah Raza et al, 2022, International Journal of Molecular Sciences CrossRef
4. The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target
   Samar Sami Alkafaas et al, 2024, Cancer Cell International CrossRef